Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for approximately Rs 2,500 crore. The acquisition aims to boost Zydus's global ...
The proposed acquisition shall act as a platform to execute our global MedTech strategy and a natural extension for Zydus having a proven track record in life sciences and wellness segments ...
Zydus Lifesciences Limited received final approval from the US Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2 per cent, according to the announcement issued by the ...
Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...
Completion of the transaction to be followed by mandatory simplified tender offer Zydus has entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical ...
Zydus Lifesciences has entered exclusive negotiations to acquire a controlling stake in France-based medtech firm Amplitude Surgical SA for €256.8 million, the drugmaker said on Tuesday, as it ...
Zydus Lifesciences Ltd has received final approval from the United States Food and Drug Administration (USFDA) to produce the antifungal drug Ketoconazole Shampoo, 2%. The approval is valid for ...
Drawing lessons from his own 20s, he listed out 20 things that he wished someone had told him. His guide begins by saying: “It is ok to not feel connected anymore with your school/college friends.
We’ve got to get away from this woke agenda and we’ve got to get back to basics — phonics, just regular core math — stop all this ridiculous confusing the kids with drawing boxes and all ...
Zydus Lifesciences on Monday said it has received approval from US health regulator USFDA to market a generic antifungal medication to treat dandruff, fungal infections, and other skin conditions. The ...
Stay ahead of the market—watch now The Rs 500 crore club represents the pinnacle of success in Indian cinema, highlighting films that have achieved exceptional domestic box office milestones.
Nippon India Small Cap Fund - Direct (IDCW) 467.76 29,95,942 0.92 Nippon India Small Cap Fund - Direct (G) 467.76 29,95,942 0.92 Nippon India Small Cap Fund - Direct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results